Charles Raison, M.D.
Phone: Development of novel treatments for major depressive disorder, and understanding mechanisms of action for these interventions.
- Raison Research Group
- UW Directory
- Charles L. Raison
- UW Health
- Provider Profile
- Recent Publications
- Pub Med
Dr. Raison is a the Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families in the School of Human Ecology and a Professor in the Department of Psychiatry at the University of Wisconsin – Madison. Dr. Raison received his medical degree from Washington University in St Louis, Missouri, where he was elected to Alpha Omega Alpha and won the Missouri State Medical Association Award. He completed residency training at the UCLA Neuropsychiatric Institute and Hospital in Los Angeles. In addition to his medical training, Dr. Raison obtained his Masters of English from the University of Denver.
Dr. Raison has written and published over 100 scientific papers as well over 20 review papers and editorials. Chapters he has written have been featured in over 30 books, and he has written two books, most recently The New Mind-Body Science of Depression, published by WW Norton in 2017. Dr. Raison’s publications have been cited over 14,000 times, with three publications having more than 1,000 citations. His H-index is 44. The recipient of several teaching awards, Dr. Raison has received research funding from the National Institute of Mental Health, National Center for Complementary and Alternative Medicine, and the Centers for Disease Control and Prevention. His visionary work focuses on the treatment of depression in response to illness and stress, translating neurobiological findings into novel interventions. In addition to his activities at University of Wisconsin-Madison, Dr. Raison is the mental health expert for CNN.com.
- Treatment of Major Depressive Disorder
- A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers
- Whole-Body Hyperthermia for the Treatment of Major Depressive Disorder: A Randomized Clinical Trial
- The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D)